Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
CD123 CAR-T cells
Locations
1
China
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Start Date
December 1, 2019
Primary Completion Date
December 31, 2023
Completion Date
July 1, 2024
Last Updated
April 18, 2023
NCT06285890
NCT07388563
NCT06311227
NCT00106925
NCT06852222
NCT06220162
Lead Sponsor
Chongqing Precision Biotech Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions